Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Delhi High Court stays Centres circular banning manufacture, sale of e-cigarettes

      Delhi High Court stays Centres circular banning manufacture, sale of e-cigarettes

      Medical Dialogues Bureau20 May 2019 9:15 AM IST
      The Centre contended that it is yet to be determined whether e-cigarettes are safer.New Delhi: The Delhi High Court has stayed the Centre's circular...
      Tech firms tackle opioid crisis with software

      Tech firms tackle opioid crisis with software

      Medical Dialogues Bureau20 May 2019 9:00 AM IST
      The company has received approval in the United States for apps to treat opioid addiction and other kinds of substance abuse.Washington: Technology...
      Hikma Pharma backs annual outlook boosted by medicine demand

      Hikma Pharma backs annual outlook boosted by medicine demand

      Medical Dialogues Bureau19 May 2019 9:20 AM IST
      Hikma Pharma expects annual revenue from its injectables division to be between $850 million and $900 million and it's generics unit to be between...
      Met Museum: No more money from family connected to OxyContin

      Met Museum: No more money from family connected to OxyContin

      Medical Dialogues Bureau19 May 2019 9:00 AM IST
      NEW YORK: The Metropolitan Museum of Art on Wednesday said it would stop taking monetary gifts from members of the Sackler family who are connected to...
      Democrats push bill on health care, drug prices through House

      Democrats push bill on health care, drug prices through House

      Medical Dialogues Bureau19 May 2019 9:00 AM IST
      The measure forced Republicans into the uncomfortable political position of casting a single vote on legislation that contained popular drug pricing...
      Valsartan suppliers faulted over data, bugs, dirt: Report

      Valsartan suppliers faulted over data, bugs, dirt: Report

      Medical Dialogues Bureau18 May 2019 9:15 AM IST
      Cadila Healthcare Ltd. and Alkem Laboratories Ltd. both won approvals in March from the Food and Drug Administration to make generic versions of...
      Bayer says wont tolerate unethical behaviour as France probes Monsanto file

      Bayer says wont tolerate unethical behaviour as France probes Monsanto file

      Medical Dialogues Bureau18 May 2019 9:00 AM IST
      Bayer, which acquired Monsanto in a $63 billion deal last year, faces mounting litigations over its weedkiller Roundup, a systemic, broad-spectrum...
      Roche gets USFDA nod for combo drug Venclexta, Gazyva to treat lymphocytic leukaemia

      Roche gets USFDA nod for combo drug Venclexta, Gazyva to treat lymphocytic leukaemia

      Medical Dialogues Bureau17 May 2019 9:15 AM IST
      "Venclexta plus Gazyva is the only chemotherapy-free option of fixed duration that provides durable responses to help people live longer without...
      Five more US states sue OxyContin maker Purdue Pharma over opioid epidemic

      Five more US states sue OxyContin maker Purdue Pharma over opioid epidemic

      Medical Dialogues Bureau17 May 2019 9:00 AM IST
      OxyContin maker Purdue Pharma called the new lawsuits “misleading attacks,” and said it will defend itself against them.U.S: Five U.S. states on...
      JnJ to submit applications for at least 10 new drugs by 2023

      JnJ to submit applications for at least 10 new drugs by 2023

      Medical Dialogues Bureau16 May 2019 9:15 AM IST
      This is part of the healthcare conglomerate’s plan to deliver above-market growth through 2023 at its Janssen unit, JnJ said.New Delhi: Johnson &...
      Students appeal to PM to enforce ban on e-cigarettes

      Students appeal to PM to enforce ban on e-cigarettes

      Medical Dialogues Bureau16 May 2019 9:00 AM IST
      "Students as young as 13 are using e-cigarettes as a fun device and later on getting addicted to it."New Delhi: Over 1000 students and teachers along...
      Mifeprex sale via mail in US; lawmakers urge USFDA to crackdown on firms

      Mifeprex sale via mail in US; lawmakers urge USFDA to crackdown on firms

      Medical Dialogues Bureau15 May 2019 9:40 AM IST
      Mifeprex is an oral drug that blocks the progesterone hormone necessary for a pregnancy to continue. It is used with Misprostol to end early...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok